Fighting Against Resistant Bacteria

An international team is working to develop new drugs that could effectively treat antibiotic-resistant bugs.

The public-private partnership is being called CARB-X, for “Combatting Antibiotic Resistant Bacteria Biopharmaceutical Accelerator.” It will bring together experts from inside the U.S government, as well as Britain’s Wellcome Trust and other academic, industry and non-governmental organizations.

One goal is to make up to $350 million in research funding available over the next five years, aimed at developing new forms of antibiotics. There have been zero new classes of antibiotics developed since the mid-1980s. Meanwhile, antibiotic resistant germs have recently been discovered inside human bodies in the United States.

“Today the world can be a little more optimistic that we can together tackle this challenge,” the Wellcome Trust’s Stephen Caddick tells reporters.

Image Credit: Thinkstock

Sourced from: The Washington Post, Major global partnership to speed antibiotic development launched